The prognosis for individuals with CARASIL is progressive neurological decline over the course of 10-20 years after the onset of symptoms, ultimately ending in death. CARASIL is a degenerative disease, and most patients live only 10 years past symptom onset, although some may live for 20-30 more years.
Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy
Hereditary cystatin C amyloid angiopathy
Walker–Warburg syndrome
Hereditary diffuse leukoencephalopathy with spheroids
Cerebral amyloid angiopathy
Familial British dementia
Moyamoya disease
Subacute sclerosing panencephalitis